Frontlight ResearchEarly access
Trial site
Medical University Of Lausitz Carl Thiem
- 13running trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma2 trials
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Down syndrome1 trial
- Multiple sclerosis1 trial
- Prostate cancer1 trial
- Stroke1 trial
- Triple-negative breast cancer1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 313 trials
- Phase 11 trial
- Status
- Recruiting10 trials
- Not yet recruiting2 trials
- Active, not recruiting1 trial
- Suspended1 trial
- Lead sponsor
- Novartis Pharma AG2 trials
- Takeda2 trials
- AbbVie1 trial
- Airna Corp.1 trial
- Bristol-Myers Squibb1 trial
- and 7 more
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Active, not recruiting
Active, not recruiting
Recruiting
Enrolling by invitation
Active, not recruiting
Comparison of Carboplatin and Cisplatin in patients with extracranial malignant germ cell tumours
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma2 recruiting
- Acute myeloid leukaemia1 recruiting
- Multiple sclerosis1 recruiting
- Prostate cancer1 recruiting
- Stroke1 recruiting
- Triple-negative breast cancer1 recruiting
- Ulcerative colitis1 recruiting
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026